Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
9/13/2025
Bayer Expands China Presence with New Innovation Platform and Biotech ...
9/13/2025
China to Incorporate HPV Vaccines into National Immunization Program
9/13/2025
Nanjing's Triastek Builds World's Largest 3D-Printed Pharma Plant
9/13/2025
CDE Seeks Public Opinions on New HIV/AIDS Drug Guidelines
9/13/2025
CDE Releases New, Comprehensive Guidelines for Innovative Drug Trial A...
9/13/2025
CDE Introduces New Risk Management Guidelines for Innovative Drugs
9/13/2025
CDE Releases First Technical Guidelines for GLP-1 Drugs
9/13/2025
Denovo's Publishes Landmark Trial in Precision Psychiatry in JAMA
9/13/2025
NMPA Releases 96th Batch of Reference Formulations for Generic Drug Ev...
9/12/2025
China NMPA Drastically Shortens Drug Trial Review Times with New Polic...
9/12/2025
China Approves FirboX's Fibroblast-Based Therapy for Clinical Trials
9/12/2025
CDE Seeks Feedback on Draft Guidance for Post-Approval Changes in Biol...
9/12/2025
CDE Solicits Input on Draft Guidance for Chronic Rhinosinusitis with N...
9/12/2025
CDE Seeks Feedback on Draft Guidance for Depression Drug Clinical Tria...
9/12/2025
CDE Solicits Comments on Draft Guidance for Insomnia Drug Clinical Tri...
9/12/2025
U.S. House Passes Bill That Could Sever Much of U.S.-China Academic Re...
9/11/2025
RabPharma Raises Oversubscribed Series A++ to Push Ahead with RAB001d ...
9/11/2025
Novartis Gains Expanded Approval for Tabrecta in China
9/11/2025
Henlius' HLX43 Shows Promising Results in Phase I Trial
9/11/2025
IDEAYA's IDE849 Shows Strong Results in Phase I Trial
9/11/2025
HKU-Med, GBAICTI and GSK Join Forces to Boost Real-World Clinical Rese...
9/11/2025
Chinese Biotechs Face Rising Hurdles in Advanced Therapies
9/10/2025
Trump Admin Weighs Tighter Curbs on U.S. Licensing of China-Originated...
9/10/2025
YolTech Secures $45M to Accelerate CRISPR Therapy Development Amid U.S...
9/9/2025
China's NMPA Seeks Public Feedback on Draft Guidelines for Online Pres...
9/9/2025
China's PD-(L)1 Market Shows Continued Growth in H1 2025, Domestic Bra...
9/9/2025
RemeGen's Telitacicept Advances in Sjögren's Syndrome
9/9/2025
BioNTech and BMS Report Promising Global Phase II Data for Pumitamig
9/8/2025
NHSA Seeks Feedback on Draft Implementation Rules for Medical Insuranc...
9/8/2025
CDE Opens Public Consultation on Draft Guidelines for Clinical Trials ...
Page:
1
/
58
Total number of articles:
1735
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit